Diabetes mellitus (DM) is a severe chronic metabolic disease with increased mortality and
morbidity. The pathological progression of DM is intimately connected with the formation and …

Metabolic syndrome (MS) is the term for a combination of hypertension, dyslipidemia, insulin
resistance, and central obesity as factors leading to cardiovascular and metabolic disease …

Cancer is the second leading cause of death worldwide. Majority of recent research efforts in
the field aim to address why cancer resistance to therapy develops and how to overcome or …

Metabolic syndrome (MetS) is a chronic disease, including abdominal obesity, dyslipidemia,
hyperglycemia, and hypertension. It should be noted that the occurrence of MetS is closely …

Obesity has become a worldwide issue and is accompanied by serious complications.
Western high energy diet has been identified to be a major factor contributing to the current …

Scope Methylglyoxal (MG)‐derived advanced glycation end products (AGEs) directly bind to
the receptor for advanced glycation end products (RAGE), subsequently exacerbating …

Cardiometabolic disease (CMD) is a leading cause of death worldwide and encompasses
the inflammatory metabolic disorders of obesity, type 2 diabetes mellitus, nonalcoholic fatty …

Accumulating evidence suggests that de novo lipogenesis is a typical characteristic
facilitating nonalcoholic fatty liver disease (NAFLD) progression. Gallic acid (GA) is a …

Background & aims The prevention and treatment of non-alcoholic fatty liver disease
(NAFLD) has become one of the most urgent problems to be solved. To date, only a lifestyle …

Aims The aim of the present study was to evaluate the oral resveratrol effects associated
with diet and physical training changes on anthropometric and biochemical parameters …